| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 436092000 | Diverse hetero atoms in same or different rings (e.g., alkaloids, opiates, etc.) | 18 |
| 20080241948 | Mycophenolate mofetil impurity - Provided is an impurity of mycophenolate mofetil, processes for its preparation and its use as a reference. | 10-02-2008 |
| 20080241949 | Process for preparing quetiapine fumarate - Provided is an improved synthesis of quetiapine and pharmaceutically acceptable salts. | 10-02-2008 |
| 20080261318 | Signalling Compounds For Use In Methods Of Detecting Hydrogen Peroxide - Methods and compound useful for detecting a source of hydrogen peroxide are disclosed wherein a signalling compound of the formula: | 10-23-2008 |
| 20090253211 | SEMICONDUCTOR NANOCRYSTAL PROBES FOR BIOLOGICAL APPLICATIONS AND PROCESS FOR MAKING AND USING SUCH PROBES - A semiconductor nanocrystal compound and probe are described. The compound is capable of linking to one or more affinity molecules. The compound comprises (1) one or more semiconductor nanocrystals capable of, in response to exposure to a first energy, providing a second energy, and (2) one or more linking agents, having a first portion linked to the one or more semiconductor nanocrystals and a second portion capable of linking to one or more affinity molecules. One or more semiconductor nanocrystal compounds are linked to one or more affinity molecules to form a semiconductor nanocrystal probe capable of bonding with one or more detectable substances in a material being analyzed, and capable of, in response to exposure to a first energy, providing a second energy. Also described are processes for respectively: making the semiconductor nanocrystal compound; making the semiconductor nanocrystal probe; and treating materials with the probe. | 10-08-2009 |
| 20100330685 | DIAMINORHODAMINE DERIVATIVE - A compound represented by the following formula (I) or (II): | 12-30-2010 |
| 20110086428 | METHOD AND DEVICE FOR MONITORING MEDICATION USAGE - The present invention provides methods for detecting and quantifying metabolites in a biological sample by measuring the concentration of a test metabolite in the sample and comparing that concentration against the concentration of the reference metabolite; enabling accurate metabolite concentration measurements to determine aberrant drug usage patterns. Also disclosed is an analytical testing device and related computer-assisted products for detecting and quantifying metabolites in a biological sample efficiently and accurately. | 04-14-2011 |
| 20110217786 | OPTIMIZED TIME TEMPERATURE INDICATOR - The present invention relates to a time temperature indicator comprising a spiropyran in a colored state and a modifier which is able to control the coloration and decoloration kinetics. The modifier which must be able to form with the spiropyran mixed solids with an amorphous, crystalline or mixed amorphous-crystalline structure. | 09-08-2011 |
| 20110269242 | TIME TEMPERATURE INDICATOR COMPRISING INDOLENIN BASED SPIROPYRANS - The present invention relates to time-temperature indicator (TTI) systems comprising indolenin based spiropyrans containing a cyclohexyl residue of formula (I), a method of manufacturing the time temperature indicator system, and a method of determining the time temperature history of perishable goods using the system. Moreover, the invention relates to a matrix selected from a printing ink or printing ink concentrate, paint, varnish, label, packaging material, and polymeric material comprising the system. | 11-03-2011 |
| 20110287549 | TIME TEMPERATURE INDICATOR BASED ON THIOALKYL AND THIOARYL SUBSTITUTED SPIROAROMATICS - The present invention relates to photochromic spiropyrans as active ingredients of Time-Temperature Indicators (TTIs), and to new spiropyrans per se. More particularly, the invention provides TTIs on the base of photochromic spiropyrans comprising alkylsulfanyl/arylsulfanyl substituents in the phenyl ring of the benzopyrane moiety. | 11-24-2011 |
| 20120220039 | METHOD AND SYSTEM FOR DETECTING RESIDUAL POISON IN HUMAN BODY - A method and system for detecting residual poison in human body are provided. Using the disclosed HPLC-Chip-mass spectrometry (MS)/MS and/or HPLC-MS/MS method to detect the residual poison, the method of the present invention mainly includes sample preparation, liquid chromatography and mass spectrometry. The method of the present invention has advantages of low sample size, high specificity, low detection limit, high sensitivity, low cost, high accuracy and stability, etc. | 08-30-2012 |
| 20120276644 | Method for Detecting Endogenous Biomolecules - Provided is a method for the real-time visualization of an endogenous biomolecule to clarify the mechanisms of various diseases and enable diagnosis and treatment of these diseases. Specifically provided is a novel method for visualizing an endogenous biomolecule by using a magnetic resonance method (including Overhauser MRI and the electron spin resonance method). The aforesaid visualization method, whereby an endogenous biomolecule is visualized on a real-time basis, comprises: a step for treating a living organism to be examined by a magnetic resonance method and thus acquiring data of the endogenous biomolecule; a step for processing the data of the endogenous biomolecule thus obtained to give imaging data; and a step for displaying the imaging data thus obtained. | 11-01-2012 |
| 20130052744 | METHODS AND DEVICES FOR DETECTING ISOTHIAZOLONES - Methods for quantitative determination of the presence of isothiazolone compounds in a solution include controlling pH of the solution in a range from about 3 to about 10, combining a known quantity of the pH-adjusted solution with a known quantity of an aromatic thiolate anion, quantitatively determining color intensity of the resultant combined solution; and correlating the color intensity with amount of isothiazolone compounds. The methods may be used in automated systems, including systems utilizing optical sensor devices. | 02-28-2013 |
| 20130109103 | METHOD FOR DETECTING PEROXIDE EXPLOSIVES | 05-02-2013 |
| 20130137183 | AIRCRAFT SCREENING DEVICE AND METHOD - A method of screening aircraft passengers and/or cargo comprising loading an aircraft with passengers, cargo or both, circulating air within the aircraft so that the air is in contact with the passengers and/or cargo, expelling some of the circulated air from the aircraft, diverting a portion of the air being expelled from the aircraft through a chemical filter configured to retained evidence of a target substance, and analyzing the chemical filter to detect the presence of a target substance within the aircraft. | 05-30-2013 |
| 20130309775 | POLYMER FOR FILLER FOR PREPROCESSING COLUMN - It is a subject of the present invention to provide a novel polymer; a filler for measuring a perfluoro compound having an acidic group at terminal which comprises said polymer; a column filled with said filler; and a measuring method for a perfluoro compound having an acidic group at terminal by using said column; as well as a filler for measuring a drug comprising the above-described polymer; a column filled with said filler; and a measuring method for a drug by using said column. | 11-21-2013 |
| 20140147925 | Method for Profiling Phytohormone Levels in Plant Tissue - The present invention provides a method for profiling phytohormone levels in plant tissue or tissue of other plastid containing organisms, i.e. a method for the simultaneous determination of a multitude of phytohormone levels in plant tissue or tissue of other plastid containing organisms, which method comprises the following steps:
| 05-29-2014 |
| 20150017732 | COLORIMETRIC METHOD TO DETECT ILLICIT DRUGS - A colorimetric assay to detect certain compounds and a kit therefore are provided. | 01-15-2015 |
| 20150017733 | Method and Device for Monitoring Medication Usage - The present invention provides methods for detecting and quantifying metabolites in a biological sample by measuring the concentration of a test metabolite in the sample and comparing that concentration against the concentration of the reference metabolite; enabling accurate metabolite concentration measurements to determine aberrant drug usage patterns. Also disclosed is an analytical testing device and related computer-assisted products for detecting and quantifying metabolites in a biological sample efficiently and accurately. | 01-15-2015 |
